Feasibility, safety, and preliminary proof of principles of autologous neural stem cell treatment combined with T-CELL vaccination for ALS patients

Cell Transplantation

Volumn 21, Issue SUPPL. 1, 2012, Pages

  Moviglia, G A ^a   Moviglia Brandolino, M T ^a   Varela, G S ^a   Albanese, G ^a   Piccone, S ^a   Echegaray, G ^a   Martinez, G ^a   Blasseti, N ^a   Farias, J ^a   Farina, P ^a   Perusso, A ^a   Gaeta, C A ^a  

^a DEPARTAMENTO DE CIENCIAS NATURALES Y ANTROPOLOGÍA   (Argentina)

Author keywords

Amyotrophic lateral sclerosis (ALS); Neural stem cells; T cell vaccination (TCV)

Indexed keywords

T LYMPHOCYTE VACCINE; UNCLASSIFIED DRUG; VACCINE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EFFECTOR CELL; FEASIBILITY STUDY; FEMALE; FLU LIKE SYNDROME; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; MALE; MINIMALLY INVASIVE PROCEDURE; NEURAL STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; RATING SCALE; SAFETY; SURVIVAL; T LYMPHOCYTE; VACCINATION;

ANIMALIA;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MALE; MIDDLE AGED; NEURAL STEM CELLS; T-LYMPHOCYTES; TRANSPLANTATION, AUTOLOGOUS;

EID: 84930473082     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X633770     Document Type: Article

References (25)

1. Angelov, D. N.; Waibel, S.; Guntinas-Lichius, O.; Lenzen, M.; Neiss, W. F.; Tomov, T. L.; Yoles, E.; Kipnis, J.; Schori, H.; Reuter, A.; Ludolph, A.; Schwartz, M. Thera-peutic vaccine for acute and chronic motor neuron diseases: Implications for amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 100(8):4790-4795; 2003.
2. Beers, D. R.; Henkel, J. S.; Zhao, W.; Wang, J.; Appel, S. H. CD4 T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc. Natl. Acad. Sci. USA 105:15558-15563; 2008.
3. Brooks, B. R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J. Neurol. Sci. 124(Suppl.):96-107; 1994.
4. Chi, L.; Ke, Y.; Luo, C.; Li, B.; Gozal, D.; Kalyanaraman, B.; Liu, R. Motor neuron degeneration promotes neural progenitor cell proliferation, migration, and neurogenesis in the spinal cords of amyotrophic lateral sclerosis mice. Stem Cells 24(1):34-43; 2006.
5. Chiua, I. M.; Chenb, A.; Zhenga, Y.; Kosarasc, B.; Tsiftsogloua, S. A.; Vartanianc, T. K.; Brown, Jr., R. H.; Carrolla, M. C. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc. Natl. Acad. Sci. USA 105:17913-17918; 2008.
6. CIOMS recommendation. Expedited Safety Reporting Requirements for Human Drug and Biological Products 21 CFR Parts 20, 310, 312, 314, and 600. Fed. Reg. 62: 194; 1997.
7. Cudkowic, M.; Qureshi, M.; Shefner, J. Measures and markers in amyotrophic lateral sclerosis. NeuroRx 1(2): 273-283; 2004.
8. Fiala, M.; Chattopadhay, M.; La Cava, A.; Tse, E.; Liu, G.; Lourenco, E.; Eskin, A.; Liu, P. T.; Magpantay, L.; Tse, S.; Mahanian, M.; Weitzman, R.; Tong, J.; Nguyen, C.; Cho, T.; Koo, P.; Sayre, J.; Martinez-Maza, O.; Rosenthal, M. J.; Wiedau-Pazos, M. IL-17A is increased in the serum, and in spinal cord CD8 and mast cells of ALS patients. J. Neuroinflammation 7:76; 2010.
9. Kabat, H.; Knott, M. Propioceptive facilitation techniques for treatment of paralysis. Phys. Ther. Rev. 33(2):53-64; 1953.
10. Kipnis, J.; Avidan, H.; Caspi, R. R.; Schwartz, M. Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: A dialogue with microglia. Proc. Natl. Acad. Sci. USA 101(Suppl. 2):14663-14669; 2004.
11. Lindvall, O.; Bjorklund, A. Cell therapy in Parkinson's disease. NeuroRx 1(4):382-393; 2004.
12. Mitrecic, D.; Gajovic, S.; Pochet, R. Toward the treat-ments with neural stem cells: Experiences from amyotrophic lateral sclerosis. Anat. Rec. 292(12):1962-1967; 2009.
13. Moisse, K.; Strong, M. J. Innate immunity in amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1762:10831093; 2006.
14. Moviglia, G. A. Immunomodulation of the injury/repair response of the cns resident innate immune system as ther-apeutic approach for amyotrophic lateral sclerosis In: Ibarra, A., ed. The role of immune cells in neurodegenera-tive diseases. Kerala, India: Research Signpost; 2008: 181-192.
15. Moviglia, G. A.; Fernandez Vina, R.; Brizuela, J. A.; Saslavsky, J.; Vrsalovic, F.; Varela, G.; Bastos, F.; Farina, P.; Etchegaray, G.; Barbieri, M.; Martínez, G.; Picasso, F.; Schmidt, Y.; Brizuela, P.; Gaeta, C. A.; Costanzo, H.; Moviglia Brandolino, M. T.; Merino, S.; Pes, M. E.; Veloso, M. J.; Rugilo, C.; Tamer, I.; Schuster, G. S. Combined protocol of cell therapy for chronic spinal cord injury. Report on the electrical and functional recovery of two patients. Cytotherapy 8(3):202-209; 2005.
16. Moviglia, G. A.; Varela, G.; Brizuela, J. A.; Moviglia Brandolino, M. T.; Farina, P.; Etchegaray, G.; Piccone, S.; Hirsch, J.; Martinez, G.; Marino, S.; Deffain, S.; Coria, N.; Gonzaíles, A.; Sztanko, M.; Salas-Zamora, P.; Previgliano, I.; Aingel, V.; Farias, J.; Gaeta, C. A.; Saslavsky, J.; Blasseti, N. Case report on the clinical results of a combined cellular therapy for chronic spinal cord injured patients. Spinal Cord 47(6):499-503; 2009.
17. Moviglia, G. A.; Varela, G.; Gaeta, C. A.; Brizuela, J. A.; Bastos, F.; Saslavsky, J. Autoreactive T Cells induce in vitro bone marrow mesenchymal stem cells transdifferen-tiation to neural stem cells. Cytotherapy 8(3)196-201; 2005.
18. Paola, F. A.; Arnold, M. Acupuncture and spinal cord medicine. J. Spinal Cord Med. 26(1):12-20; 2003.
19. Ryu, H.; Ferrante, R. J. Translational therapeutic strategies in amyotrophic lateral sclerosis. Mini Rev. Med. Chem. 7: 141-150; 2007.
20. Sadowska, L. Vaclav Vojta's neurokinesiological concept for the diagnosis and therapy of children with disturbances of motor development. Ortop. Traumatol. Rehabil. 3(4): 519-526; 2001.
21. Shi, N.; Kawano, Y.; Tateishi, T.; Kikuchi, H.; Osoegawa, M.; Ohyagi, Y.; Kira, J. Increased IL-13-producing T cells in ALS: Positive correlations with disease severity and progression rate. J. Neuroimmunol. 182:232-235; 2007.
22. Swash, M. Stem cell therapy in human ALS. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 4(3):133-134; 2003.
23. US Department of Health and Human Services; FDA; CDER; CBER; ORA. Guidance for industry. Sterile drug products produced by aseptic processing-current good manufacturing practices. Rockville, MD: US Department of Health and Human Services Food and Drug Administration; 2004.
24. Vandenbark, A. A.; Abulafia-Lapid, R. Autologous T-cell vaccination for multiple sclerosis: A perspective on prog-ress. BioDrugs 22:265-273; 2008.
25. Yan, J.; Xu, L.; Welsh, A. M.; Chen, D.; Hazel, T.; Johe, K.; Koliatsos, V. E. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice. Stem Cells 24(8):1976-1985; 2006.